1.13
전일 마감가:
$0.8191
열려 있는:
$0.9744
하루 거래량:
63.88M
Relative Volume:
44.73
시가총액:
$4.42M
수익:
-
순이익/손실:
$-9.34M
주가수익비율:
-0.1583
EPS:
-7.14
순현금흐름:
$-6.69M
1주 성능:
+32.94%
1개월 성능:
+15.32%
6개월 성능:
-22.07%
1년 성능:
-65.23%
패인리폼 Stock (PRFX) Company Profile
명칭
Prf Technologies Ltd
전화
-
주소
-
PRFX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PRFX
Painreform Ltd
|
1.13 | 3.21M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
패인리폼 주식(PRFX)의 최신 뉴스
Merger Talk: What is the PEG ratio of PainReform LtdJuly 2025 Technicals & Trade Opportunity Analysis Reports - baoquankhu1.vn
PRF Technologies Embraces Diversification with Bold Strategic Expansion - StocksToTrade
PRF Technologies Expands Beyond Pharmaceuticals with New Strategic Directions - timothysykes.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
PainReform Stock Spikes As It Rebrands, Expands Beyond Pharma With AI, Clean Energy Push - Benzinga
PainReform PRFX stock jumps in premarket after company rebrands as PRF Technologies - TechStock²
PainReform's Corporate Name Changes To PRF Technologies To Reflect Expansion; Stock Up - Nasdaq
Why PainReform Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket - Benzinga
Gelion PLCProf. Rachid Yazami Appointed Technology Advisor - Research Tree
From pain drug to AI solar: PRF Technologies pivots into two big markets - Stock Titan
PainReform Transforms to PRF Technologies, Maintains Ticker PRFX - GuruFocus
PainReform Rebrands as PRF Technologies to Reflect Expansion into Healthcare and AI-Driven Energy - TipRanks
PRF Technologies rebrands to reflect diversified business model - Investing.com
PRF Technologies Ltd. Changes Corporate Name to Reflect Strategic Diversification Amid Growth Initiatives - Quiver Quantitative
PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms - Weekly Voice
PainReform Ltd. Changes Name to PRF Technologies Ltd. - GlobeNewswire
“To hell with them” – Prof. Frimpong-Boateng fires back at NPP - CitiNewsroom.com
Moving Averages: Is PainReform Ltd impacted by rising ratesWeekly Gains Summary & Technical Confirmation Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
PainReform Reports Positive Phase I Safety Data for OcuRing-K Ocular Drug Platform - TipRanks
PainReform Ltd. and LayerBio, Inc. Announces Safety Data Supporting the Continued Development of OcuRing-K Drop-less, Sustainable-Release Ocular Drug Delivery Platform for Use in Cataract Surgery - marketscreener.com
PainReform’s LayerBio’s Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical Studies - Sahm
New drop-free eye drug implant shows early safety in cataract surgery - Stock Titan
PainReform Ltd. (PRFX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Does PainReform Ltd. stock trade at a discount to peersMarket Growth Summary & High Conviction Buy Zone Picks - Улправда
PainReform (NASDAQ:PRFX) vs. Citius Pharmaceuticals (NASDAQ:CTXR) Financial Comparison - Defense World
What analyst consensus says on PainReform Ltd. stockJuly 2025 Levels & Free Weekly Watchlist of Top Performers - Улправда
Is PainReform Ltd. stock attractive after correctionPortfolio Risk Report & Pattern Based Trade Signal System - ulpravda.ru
PainReform Files Pro Forma Financials Following Majority Acquisition of LayerBio - TipRanks
Can PainReform Ltd. stock deliver sustainable ROE2026 world cup usa national team third place match playmakers possession football match prediction preview - Улправда
PainReform Shareholders Approve All Proposals at Adjourned 2026 Annual Meeting - TipRanks
PainReform Ltd's Deepsolar Launches Smart TDD, A Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market - marketscreener.com
PainReform (PRFX) Introduces Advanced Solar Audit Service with S - GuruFocus
PainReform’s DeepSolar Unveils Smart TDD to Speed and Sharpen Solar Asset Due Diligence - TipRanks
PainReform Ltd. Launches Smart TDD: Advanced Solar Technical Due Diligence Service to Enhance Asset Performance and Risk Assessment - Quiver Quantitative
PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market - Yahoo Finance
PainReform Adjourns Annual Shareholder Meeting Due to Lack of Quorum - TipRanks
AI drones join $600B push to keep UAE and Middle East solar farms efficient - Stock Titan
PainReform’s LayerBio platform advances with multi-drug capability - MSN
Is PainReform Ltd stock attractive after correctionWeekly Stock Summary & Weekly Watchlist for Hot Stocks - moha.gov.vn
Why PainReform Ltd. stock remains on buy listsTrade Risk Summary & Daily Oversold Stock Bounce Ideas - Улправда
Can PainReform Ltd. stock surprise with earnings upside2025 Price Action Summary & Growth Focused Entry Reports - Улправда
Published on: 2025-12-19 20:32:49 - Улправда
Published on: 2025-12-19 20:05:02 - Улправда
Is PainReform Ltd. stock overvalued by current metricsWeekly Trend Recap & Daily Volume Surge Signals - Улправда
What hedge fund activity signals for PainReform Ltd. stockPrice Action & Long-Term Investment Growth Plans - DonanımHaber
How risky is PainReform Ltd. stock nowWall Street Watch & Long-Term Safe Investment Ideas - DonanımHaber
Is PainReform Ltd. stock attractive for income investorsWeekly Stock Summary & AI Powered Market Trend Analysis - Улправда
PAU prof awarded for developing eco-friendly insect-pest management technologies - The Indian Express
What drives PainReform Ltd stock priceTop Performing Stocks & Download Our Free Trading Blueprint - earlytimes.in
PainReform completed R&D assessment of LayerBio’s drug-delivery platform - MSN
패인리폼 (PRFX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):